药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
19-Nor-4-androstenedione
Prenylamine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Prenylamine.
19-Nor-4-androstenedione
Terlipressin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Terlipressin.
19-Nor-4-androstenedione
Aceprometazine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Aceprometazine.
19-Nor-4-androstenedione
Probucol
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Probucol.
19-Nor-4-androstenedione
2,5-Dimethoxy-4-ethylthioamphetamine
2,5-Dimethoxy-4-ethylthioamphetamine may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
Gepefrine
Gepefrine may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
Methoxyphenamine
Methoxyphenamine may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
Mephedrone
Mephedrone may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
Ritobegron
Ritobegron may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
Iofetamine I-123
Iofetamine I-123 may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
Methylenedioxyethamphetamine
Methylenedioxyethamphetamine may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
Chlorphentermine
Chlorphentermine may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
Tenamfetamine
Tenamfetamine may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
4-Bromo-2,5-dimethoxyamphetamine
4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
2,5-Dimethoxy-4-ethylamphetamine
2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative and stimulatory activities of Bilastine.
19-Nor-4-androstenedione
Betahistine
The therapeutic efficacy of Betahistine can be decreased when used in combination with Bilastine.
Indopan
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Asunaprevir.
Indopan
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Asunaprevir.
Indopan
Filgotinib
The serum concentration of Asunaprevir can be increased when it is combined with Filgotinib.
Indopan
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Asunaprevir.